Cite
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology.
MLA
Lieberman, Jay A., et al. “A Systematic Review and Expert Delphi Consensus Recommendation on the Use of Vaccines in Patients Receiving Dupilumab: A Position Paper of the American College of Allergy, Asthma and Immunology.” Annals of Allergy, Asthma & Immunology, vol. 133, no. 3, Sept. 2024, pp. 286–94. EBSCOhost, https://doi.org/10.1016/j.anai.2024.05.014.
APA
Lieberman, J. A., Chu, D. K., Ahmed, T., Dribin, T. E., Abrams, E. M., Anagnostou, A., Blumenthal, K. G., Boguniewicz, M., Chase, N. M., Golden, D. B. K., Hartog, N. L., Heimall, J. R., Ho, T., Lawrence, M. G., Khan, D. A., Minniear, T. D., Mustafa, S. S., Oppenheimer, J. J., Phillips, E. J., & Ramsey, A. (2024). A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology. Annals of Allergy, Asthma & Immunology, 133(3), 286–294. https://doi.org/10.1016/j.anai.2024.05.014
Chicago
Lieberman, Jay A., Derek K. Chu, Tasnuva Ahmed, Timothy E. Dribin, Elissa M. Abrams, Aikaterini Anagnostou, Kimberly G. Blumenthal, et al. 2024. “A Systematic Review and Expert Delphi Consensus Recommendation on the Use of Vaccines in Patients Receiving Dupilumab: A Position Paper of the American College of Allergy, Asthma and Immunology.” Annals of Allergy, Asthma & Immunology 133 (3): 286–94. doi:10.1016/j.anai.2024.05.014.